ACR GUIDELINES Bundle (free trial)

Periop ACR

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512446

Contents of this Issue

Navigation

Page 2 of 7

Treatment Table 1. Medications to CONTINUE Through Surgery DMARDs: CONTINUE these medications through surgery (all patients) Dosing Interval Recommended timing of surgery since last medication dose Methotrexate Weekly Anytime Sulfasalazine Once or twice daily Anytime Hydroxychloroquine Once or twice daily Anytime Leflunomide (Arava) Daily Anytime Doxycycline Daily Anytime Apremilast (Otezla) Twice daily Anytime SEVERE SLE-SPECIFIC MEDICATIONS:* CONTINUE these medications in the perioperative period in consultation with the treating rheumatologist Dosing Interval Recommended timing of surgery since last medication dose Mycophenolate mofetil Twice daily Anytime Azathioprine Daily or twice daily Anytime Cyclosporine Twice daily Anytime Tacrolimus Twice daily (IV and PO) Anytime Rituximab (Rituxan) IV Every 4-6 months Month 4–6 Belimumab (Benlysta) Weekly SQ Anytime Belimumab (Benlysta) Monthly IV Week 4 Anifrolumab (Saphnelo) † IV Every 4 weeks Week 4 Voclosporin (Lupkynis) † Twice daily Continue Bold indicates recommendation that has changed since 2017. * Severe SLE indicates organ threatening disease. † Drug added for 2022 update.

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Periop ACR